Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Olencki

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
The American Journal of Case Reports|May 1, 2018
Clinical Benefit from Tyrosine Kinase Inhibitors in Metastatic Merkel Cell Carcinoma: A Case Series of 5 PatientsErica S Tarabadkar, Hannah Thomas, Astrid Blom, et al.
Transplantation|October 27, 2018
Preserved Renal Allograft Function and Successful Treatment of Metastatic Merkel Cell Cancer Post Nivolumab TherapyPriyamvada Singh, Jon Visger Von, Jason Prosek, et al.
Investigational New Drugs|May 4, 2004
Phase I trial of vinorelbine and diphenylhydantoin in patients with refractory carcinomaThomas E Hutson, Ram Ganapathi, Paul Elson, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|November 23, 2006
Short communication: phase I clinical and gene modulatory evaluation of tamoxifen and IFN-alpha2bSnehal G Thakkar, David Peereboom, Thomas Olencki, et al.
Experimental Eye Research|May 10, 2012
Monosomy 3 status of uveal melanoma metastases is associated with rapidly progressive tumors and short survivalMohamed H Abdel-Rahman, Colleen M Cebulla, Vishal Verma, et al.
Cancer|December 20, 2002
Phase I trial of weekly docetaxel and gemcitabine in patients with refractory malignanciesTarek Mekhail, Thomas E Hutson, Paul Elson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2003
Phase I trial of consensus interferon in patients with metastatic renal cell carcinoma: toxicity and immunological effectsThomas E Hutson, Luis Molto, Tarek Mekhail, et al.
Urologic Oncology|January 9, 2007
Phase II trial of capecitabine and rHu-interferon-alpha-2a in patients with metastatic renal cell carcinoma, limited efficacy, and moderate toxicityEna Segota, Tarek Mekhail, Thomas Olencki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
IFN-alpha-2b-induced signal transduction and gene regulation in patient peripheral blood mononuclear cells is not enhanced by a dose increase from 5 to 10 megaunits/m2Jason M Zimmerer, Amy M Lehman, Amy S Ruppert, et al.
Cancer Immunology, Immunotherapy : CII|January 15, 2008
Activation of extracellular signaling regulated kinase in natural killer cells and monocytes following IL-2 stimulation in vitro and in patients undergoing IL-2 immunotherapy: analysis via dual parameter flow-cytometric assaySri Vidya Kondadasula, Kimberly A Varker, Gregory B Lesinski, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
The American Journal of Case Reports|May 1, 2018
Clinical Benefit from Tyrosine Kinase Inhibitors in Metastatic Merkel Cell Carcinoma: A Case Series of 5 PatientsErica S Tarabadkar, Hannah Thomas, Astrid Blom, et al.
Transplantation|October 27, 2018
Preserved Renal Allograft Function and Successful Treatment of Metastatic Merkel Cell Cancer Post Nivolumab TherapyPriyamvada Singh, Jon Visger Von, Jason Prosek, et al.
Investigational New Drugs|May 4, 2004
Phase I trial of vinorelbine and diphenylhydantoin in patients with refractory carcinomaThomas E Hutson, Ram Ganapathi, Paul Elson, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|November 23, 2006
Short communication: phase I clinical and gene modulatory evaluation of tamoxifen and IFN-alpha2bSnehal G Thakkar, David Peereboom, Thomas Olencki, et al.
Experimental Eye Research|May 10, 2012
Monosomy 3 status of uveal melanoma metastases is associated with rapidly progressive tumors and short survivalMohamed H Abdel-Rahman, Colleen M Cebulla, Vishal Verma, et al.
Cancer|December 20, 2002
Phase I trial of weekly docetaxel and gemcitabine in patients with refractory malignanciesTarek Mekhail, Thomas E Hutson, Paul Elson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2003
Phase I trial of consensus interferon in patients with metastatic renal cell carcinoma: toxicity and immunological effectsThomas E Hutson, Luis Molto, Tarek Mekhail, et al.
Urologic Oncology|January 9, 2007
Phase II trial of capecitabine and rHu-interferon-alpha-2a in patients with metastatic renal cell carcinoma, limited efficacy, and moderate toxicityEna Segota, Tarek Mekhail, Thomas Olencki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
IFN-alpha-2b-induced signal transduction and gene regulation in patient peripheral blood mononuclear cells is not enhanced by a dose increase from 5 to 10 megaunits/m2Jason M Zimmerer, Amy M Lehman, Amy S Ruppert, et al.
Cancer Immunology, Immunotherapy : CII|January 15, 2008
Activation of extracellular signaling regulated kinase in natural killer cells and monocytes following IL-2 stimulation in vitro and in patients undergoing IL-2 immunotherapy: analysis via dual parameter flow-cytometric assaySri Vidya Kondadasula, Kimberly A Varker, Gregory B Lesinski, et al.
Pageof 7